AstraZeneca’s Early-Stage Trials of Experimental Cancer Drug are Encouraging

June 4, 2014 2:18 PM

9 0

AstraZeneca’s Early-Stage Trials of Experimental Cancer Drug are Encouraging

At the annual American Society of Clinical Oncology (ASCO) meeting held in Chicago, Britain's AstraZeneca Plc announced about fruitful results from early-stage trials of its experimental cancer drug, MEDI4736.

Sharing the data, the company said they can move into pivotal-stage testing. MEDI4736 is part of closely monitored drugs called as anti-PDL1 therapies. They work by stopping a tumor's ability to escape immune system's defenses.

Read more

To category page

Loading...